echoloc/ Companies/ Mount Sinai Morningside

Company profile

Mount Sinai Morningside Tech Stack

Neighborhood teaching hospital with trauma care and translational research labs

Hospitals and Health Care New York 1,001–5,000 employees Founded 1846 Nonprofit

Mount Sinai Morningside is a nonprofit New York hospital serving Morningside Heights and West Harlem, pairing Epic/MyChart clinical systems with a research stack of Python, PyTorch, vLLM, AWS EMR, REDCap and lab tools like CyTOF and PacBio. Hiring is accelerating and dominated by clinical and research roles, while job-post pain points cluster on length of stay, readmissions and throughput, a clear operational-efficiency agenda.

Tech Stack 100 technologies

Core StackEpic Systems Python MATLAB Tableau SAS ServiceNow PL/SQL C++ PyTorch Prisma Allscripts MyChart AWS EMR vLLM Cerner Eagle Bioconductor ImageJ REDCap Epic IDX PACS Oracle Cloud Integration CyTOF PacBio RNAi ELISPOT qPCR Perl FHIR+66 more

What Mount Sinai Morningside Is BuildingChallenges and projects from their job posts

◆Challenges

Reducing patient length of stay
Reducing readmission rate
Clinical throughput and procedural efficiency
Reducing delays in diagnosis and treatment
Improving resource utilization via utilization review
Improving quality metrics

▲Active Projects

Research on cancer drug resistance drivers
Multimodal neuroimaging data analysis
Infection control program development
Purposeful hourly rounding implementation
Identifying regulators of bone degeneration in aging
Program workflow expansion

Hiring Activity

Accelerating110 roles · 55 in 30d

Department

Healthcare

Research

Ops

Engineering

Data

Finance

Legal

Product

Seniority

Junior

Mid

Staff

Senior

Manager

Director

Lead

Notable leadership hires: Research Program Director

Companies like Mount Sinai Morningside

100+ Hospitals and Health Care companies running Epic Systems and Allscripts

See the full list

About Mount Sinai Morningside

Mount Sinai Morningside is a nonprofit hospital in New York, founded in 1846, with 1,001–5,000 employees. It is the primary care provider for the Morningside Heights and West Harlem communities and operates a level 2 trauma center, with a historical strength in cardiology and cardiac surgery. Alongside clinical care, it runs research programs spanning neuroimaging, cancer drug resistance and aging-related bone degeneration. It serves a diverse local population, including residents facing social and economic hardship, and hires within the United States.

HeadquartersNew York

Company Size1,001–5,000 employees

Founded1846

Hiring MarketsUnited States

Frequently Asked Questions

What EHR system does Mount Sinai Morningside use?

Its stack includes Epic Systems with the MyChart patient portal, alongside Allscripts, Cerner, IDX, PACS and FHIR-based interoperability tooling.

Is Mount Sinai Morningside hiring?

Yes. Hiring is accelerating, led by healthcare and research roles, mostly at junior and mid levels, with a Research Program Director among notable leadership openings. All roles are in the United States.

What research is Mount Sinai Morningside working on?

Projects include multimodal neuroimaging data analysis, drivers of drug resistance in cancer, regulators of bone degeneration in aging, and a surgically induced menopause study, supported by Python, PyTorch, MATLAB and Bioconductor.

Similar Companies in Hospitals and Health Care

Other companies in the same industry, closest in size

Claritev

Hospitals and Health Care

Blue Cross Blue Shield of Massachusetts

Hospitals and Health Care

Children's National Hospital

Hospitals and Health Care

AGFA HealthCare

Hospitals and Health Care

How this profile is built

Mount Sinai Morningside's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.